Richard S. Grant Partner

Save current page as PDF

Richard is a member of the firm’s Board of Partners and serves on its Lateral Partner Integration Committee. He was the Managing Partner of the firm’s Los Angeles-Century City office from 2009 to 2022, and was a member of the firm’s Finance Committee. Richard’s practice concentrates on mergers and acquisitions and private equity-backed corporate transactions.

He regularly represents private equity funds, family offices, institutional co-investors, independent sponsors and privately held companies and his experience spans numerous industries, including healthcare, consumer, manufacturing, technology and renewable energy.

Richard works extensively with independent sponsors and leads our West Coast (Los Angeles and San Francisco) independent sponsor networks.

Along with others on our healthcare private equity team, Richard is actively involved in the firm’s annual Healthcare and Life Sciences Private Equity and Finance Conference, one of the largest private equity events in the U.S. healthcare market.

Richard has provided pro bono legal services for various organizations, including the Los Angeles County Bar Domestic Violence Project. He has served as pro bono counsel to a number of nonprofit organizations, including Garden School Foundation, a nonprofit dedicated to creating teaching gardens and related projects in schools serving underprivileged communities. He is a member of the Emeritus Council of Los Angeles Regional Food Bank and served as a member of the Board of Trustees of Temple Leo Baeck in Los Angeles.

Experience

  • Representation of private equity fund in numerous platform acquisitions (healthcare and technology)
  • Representation of private equity fund in sale of portfolio company (financial services).
  • Representation of private equity fund in add on acquisition (national oncology).
  • Representation of private equity fund in debt and equity investment in manufacturing company.
  • Representation of private equity fund in platform acquisition (national oncology).
  • Representation of private equity fund in sale of portfolio company (retail consumer).
  • Representation of private equity fund in platform acquisition (marketing and services).
  • Representation of foreign strategic buyer in acquisition of domestic bioplastics company.
  • Representation of strategic buyer in multiple acquisitions of manufacturing companies.
  • Representation of private equity buyer in acquisition of private equity portfolio company (renewable energy – – biogas).
  • Representation of private equity buyer in acquisition of renewable assets from private equity seller (solar and wind assets).
  • Representation of privately held specialty pharmacy in connection with sale to private equity buyer.
  • Representation of specialty pharmacy in private equity acquisition.
  • Representation of private equity sponsor in joint venture with another third party investor (property operations).
  • Representation in several merger and acquisition transactions of media companies to public company buyers.
  • Representation of venture investor in joint venture transaction in connection with financing for development of closed television network.
  • Representation of private equity sponsor in sale of portfolio company (manufacturing).
  • Representation of private equity sponsor in joint venture agreement and subsequent purchase of portfolio company by the joint venture (shipping and
    logistics)
  • Representation of private equity sponsor in $50,000,000 mezzanine financing of shipping and logistics company.
  • Representation of publicly held transportation company in sale of transportation logistics division.
  • Representation of privately held professional services firm in acquisition of operating division of publicly traded company.